US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

16.36

-0.1000-0.61%

Post-market: 16.360.00000.00%16:10 EDT

Volume:5.16M

Turnover:84.62M

Market Cap:51.68B

PE:72.80

High:16.54

Open:16.46

Low:16.28

Close:16.46

52wk High:18.90

52wk Low:12.99

Shares:3.16B

Float Shares:3.06B

Volume Ratio:1.50

T/O Rate:0.17%

Dividend:0.63

Dividend Rate:3.85%

EPS(TTM):0.2247

EPS(LYR):0.2245

ROE:1.50%

ROA:2.47%

PB:1.06

PE(LYR):72.88

Loading ...

Overview Company News Filings

Market Chatter: Takeda, Eli Lilly to Face Class Action Over Actos Cancer Risk

MT Newswires Live

Takeda’s EXPLORHAE HAE Study in Egypt: Real‑World Data With Long‑Term Investor Upside

These 8 drugs could help fight dementia - and they're already on the market

Takeda’s TAK-861 Narcolepsy Study Moves Forward, Extending the Long-Term Bet on Sleep Disorders

Takeda Advances Fazirsiran Phase 3 Liver Study, Keeping Rare-Disease Growth Story in Play

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires Live

Market Chatter: Takeda Pharmaceutical to Cut 400 US Jobs, Invest in Blood Products

MT Newswires Live

Press Release: Alan Walshe Appointed General Manager of Takeda Canada

Takeda, Protagonist announce FDA acceptance of rusfertide new drug application

Takeda’s Cuvitru Safety Study: What a New Japanese Registry Update Means for TAK Investors

Takeda Shares Down After Entyvio Shows Strong Results In Ulcerative Colitis Trial In Children, Shows Potential To Address Treatment Gaps

Benzinga_recent_news

Takeda Reports 47% of Patients Met Primary Endpoint in Entyvio Trial

Takeda announces data from Phase 3 KEPLER trial of ENTYVIO

Takeda’s New Stroke Trial Adds Long-Term Optionality to TAK’s Pipeline

Takeda’s HyQvia Study Tracks Real-World Use in Multiple Myeloma, Offering Gradual Upside for TAK Investors

Takeda Targets Better Hereditary Angioedema Diagnosis With New AHAE Study

Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live

Takeda Advances Phase 3 Teen Depression Trial, Underscoring Its Neuroscience Strategy

Takeda Pushes Pediatric Psoriasis Drug TAK-279 Forward With New Phase 3 Trial Update

Takeda Advances Oral Crohn’s Disease Drug TAK-279 With Active Mid-Stage Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TAK/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TAK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","market":"US","secType":"STK","nameCN":"Takeda Pharmaceutical Co Ltd","latestPrice":16.36,"timestamp":1778529600000,"preClose":16.46,"halted":0,"volume":5164343,"hourTrading":{"tag":"盘后","latestPrice":16.36,"preClose":16.36,"latestTime":"16:10 EDT","volume":1335,"amount":21840.6,"timestamp":1778530205089,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006075334143377972,"floatShares":3057000000,"shares":3159188548,"eps":0.224727,"marketStatus":"Post-Mkt","change":-0.1,"latestTime":"05-11 16:31:15 EDT","open":16.46,"high":16.535,"low":16.28,"amount":84617974.263339,"amplitude":0.015492,"askPrice":17.29,"askSize":1,"bidPrice":16.2,"bidSize":1,"shortable":3,"etf":0,"ttmEps":0.224727,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1778544000000},"marketStatusCode":4,"adr":0,"adrRate":0.5,"listingDate":1545627600000,"exchange":"NYSE","adjPreClose":16.46,"dividendRate":0.037748,"preHourTrading":{"tag":"盘前","latestPrice":16.38,"preClose":16.46,"latestTime":"09:29 EDT","volume":342,"amount":5603.550642,"timestamp":1778506191113,"change":-0.08,"changeRate":-0.00486,"amplitude":0.00486},"postHourTrading":{"tag":"盘后","latestPrice":16.36,"preClose":16.36,"latestTime":"16:10 EDT","volume":1335,"amount":21840.6,"timestamp":1778530205089,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.50186,"impliedVol":0.3619,"impliedVolPercentile":0.5817},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","floatShares":3057000000,"roa":"2.47%","roe":"1.50%","lyrEps":0.224477,"volumeRatio":1.50186,"shares":3159188548,"dividePrice":0.62964,"high":16.535,"amplitude":0.015492,"preClose":16.46,"low":16.28,"week52Low":12.99,"pbRate":"1.06","psRate":"1.82","week52High":18.895,"institutionHeld":0.1061,"latestPrice":16.36,"eps":0.224727,"divideRate":0.038487,"volume":5164343,"delay":0,"ttmEps":0.224727,"open":16.46,"prevYearClose":15.59,"prevWeekClose":16.46,"prevMonthClose":16.68,"prevQuarterClose":18.52,"fiveDayClose":16.56,"twentyDayClose":17.82,"sixtyDayClose":18.37,"earningDate":1778601600000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAK\",params:#limit:5,,,undefined,":[{"date":"2026-05-13","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/03","expectedEps":0.21,"defaultRemindTime":1778659200000,"name":null,"time":"Pre-Market","dateTimestamp":1778644800000,"actualEps":null},{"market":"US","date":"2026-01-29","symbol":"TAK","fiscalQuarterEnding":"2025/12","expectedEps":0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1769662800000,"reportTimeType":"pre","actualEps":0.48},{"date":"2025-10-30","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":0.44,"defaultRemindTime":1761811200000,"name":null,"time":"Pre-Market","dateTimestamp":1761796800000,"actualEps":0.44},{"market":"US","date":"2025-07-30","symbol":"TAK","fiscalQuarterEnding":"2025/06","expectedEps":0.47,"name":null,"time":"","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"","actualEps":0.52},{"market":"US","date":"2025-01-30","symbol":"TAK","fiscalQuarterEnding":"2024/12","expectedEps":0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.42}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1689307200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAK","date":"2026-05-08","current":72.799441,"percent":0.8968,"low":9.919003,"twenty":15.819699,"median":29.842804,"eighty":47.890056,"high":247.195474,"avg":41.710987,"sd":44.334288,"marketCap":52641729349.45},"quantilePoints":[{"date":"2021-05-14","current":15.564762,"twenty":30.470959,"median":38.145677,"eighty":91.758112,"marketCap":53496176267.97},{"date":"2021-05-21","current":15.876889,"twenty":30.319318,"median":38.091991,"eighty":91.609986,"marketCap":54795356598.76},{"date":"2021-05-28","current":15.664642,"twenty":30.236167,"median":38.041392,"eighty":91.546628,"marketCap":53587690959.61},{"date":"2021-06-04","current":15.281766,"twenty":30.057838,"median":37.818162,"eighty":91.527134,"marketCap":52499044333.6},{"date":"2021-06-11","current":15.732274,"twenty":29.940017,"median":37.70687,"eighty":91.283451,"marketCap":53886220157.49},{"date":"2021-06-18","current":15.499142,"twenty":29.705398,"median":37.644832,"eighty":91.259083,"marketCap":52855138856.99},{"date":"2021-06-25","current":15.64495,"twenty":29.653254,"median":37.496711,"eighty":91.185978,"marketCap":53110087882.29},{"date":"2021-07-02","current":15.624135,"twenty":29.556114,"median":37.309512,"eighty":90.966664,"marketCap":52790633079.89},{"date":"2021-07-09","current":15.170356,"twenty":29.369182,"median":37.239049,"eighty":90.713234,"marketCap":51765371608.86},{"date":"2021-07-16","current":15.553362,"twenty":29.036801,"median":37.034171,"eighty":90.649877,"marketCap":53089153550.44},{"date":"2021-07-23","current":15.445121,"twenty":28.610503,"median":36.990446,"eighty":90.630383,"marketCap":52540828243.5},{"date":"2021-07-30","current":13.400212,"twenty":26.987384,"median":36.968687,"eighty":90.397999,"marketCap":52641482781.37},{"date":"2021-08-06","current":13.231512,"twenty":25.788836,"median":36.881192,"eighty":90.295707,"marketCap":51739766156.6},{"date":"2021-08-13","current":13.399277,"twenty":25.542527,"median":36.851251,"eighty":90.284353,"marketCap":52624385513.69},{"date":"2021-08-20","current":13.340924,"twenty":25.375364,"median":36.822486,"eighty":90.167386,"marketCap":52391869685.63},{"date":"2021-08-27","current":13.304453,"twenty":25.07978,"median":36.81694,"eighty":90.040671,"marketCap":52184954198.97},{"date":"2021-09-03","current":13.585277,"twenty":24.895379,"median":36.800541,"eighty":89.938325,"marketCap":53414238064.1},{"date":"2021-09-10","current":13.6801,"twenty":24.732641,"median":36.787118,"eighty":89.91883,"marketCap":53684261064.92},{"date":"2021-09-17","current":13.906217,"twenty":24.583535,"median":36.72461,"eighty":89.874967,"marketCap":54565644835.19},{"date":"2021-09-24","current":13.753041,"twenty":24.444102,"median":36.66065,"eighty":89.831104,"marketCap":53563443001.25},{"date":"2021-10-01","current":13.260689,"twenty":24.187434,"median":36.617455,"eighty":89.777494,"marketCap":51482210756.95},{"date":"2021-10-08","current":11.666926,"twenty":23.93319,"median":36.601121,"eighty":89.748252,"marketCap":44862900501.13},{"date":"2021-10-15","current":11.787279,"twenty":23.7033,"median":36.578836,"eighty":89.499696,"marketCap":44516597060.99},{"date":"2021-10-22","current":11.681514,"twenty":23.539863,"median":36.5454,"eighty":88.968468,"marketCap":44293684279.19},{"date":"2021-10-29","current":10.648321,"twenty":23.423498,"median":36.488155,"eighty":88.710165,"marketCap":44164269191.12},{"date":"2021-11-05","current":10.784625,"twenty":23.226892,"median":36.468627,"eighty":88.627312,"marketCap":44983557825.66},{"date":"2021-11-12","current":10.950849,"twenty":22.951173,"median":36.398869,"eighty":88.490851,"marketCap":45493195113.2},{"date":"2021-11-19","current":10.728109,"twenty":22.593579,"median":36.365388,"eighty":88.33002,"marketCap":44596449686.83},{"date":"2021-11-26","current":10.425581,"twenty":22.055183,"median":36.25968,"eighty":88.252042,"marketCap":43512424769.26},{"date":"2021-12-03","current":10.106651,"twenty":21.515452,"median":36.172679,"eighty":88.178937,"marketCap":42286529642.36},{"date":"2021-12-10","current":10.142864,"twenty":21.321368,"median":36.088488,"eighty":87.847529,"marketCap":42348534488.31},{"date":"2021-12-17","current":10.34424,"twenty":21.015505,"median":36.02197,"eighty":87.423521,"marketCap":43082485607.36},{"date":"2021-12-23","current":10.363994,"twenty":20.795645,"median":35.82744,"eighty":87.174965,"marketCap":42874132957.12},{"date":"2021-12-31","current":10.327779,"twenty":20.657578,"median":35.632629,"eighty":86.517022,"marketCap":42437110052.52},{"date":"2022-01-07","current":10.522022,"twenty":20.640925,"median":35.562823,"eighty":86.434171,"marketCap":43033429977.32},{"date":"2022-01-14","current":11.009273,"twenty":20.536864,"median":35.556871,"eighty":86.322076,"marketCap":45750368973.66},{"date":"2022-01-21","current":10.940136,"twenty":20.171308,"median":35.520843,"eighty":86.263593,"marketCap":45488233052.08},{"date":"2022-01-28","current":10.953305,"twenty":19.949589,"median":35.455688,"eighty":85.922437,"marketCap":44994125510.56},{"date":"2022-02-04","current":12.019761,"twenty":19.86233,"median":35.393845,"eighty":85.355005,"marketCap":45736794370.02},{"date":"2022-02-11","current":12.502153,"twenty":19.831282,"median":35.308236,"eighty":85.302091,"marketCap":47298200126.65},{"date":"2022-02-18","current":12.558981,"twenty":19.671006,"median":35.308236,"eighty":85.302091,"marketCap":47834673171.52},{"date":"2022-02-25","current":12.196703,"twenty":19.550551,"median":35.308236,"eighty":85.302091,"marketCap":46263555485.74},{"date":"2022-03-04","current":12.289048,"twenty":19.380891,"median":35.308236,"eighty":85.302091,"marketCap":46976698663.99},{"date":"2022-03-11","current":12.043978,"twenty":19.117196,"median":35.308236,"eighty":85.302091,"marketCap":45095629553.81},{"date":"2022-03-18","current":12.707196,"twenty":18.980245,"median":35.308236,"eighty":85.302091,"marketCap":46769031069.82},{"date":"2022-03-25","current":12.770838,"twenty":18.858799,"median":35.308236,"eighty":85.302091,"marketCap":45895036970.15},{"date":"2022-04-01","current":12.530413,"twenty":18.69121,"median":35.308236,"eighty":85.302091,"marketCap":44742437445.66},{"date":"2022-04-08","current":13.064299,"twenty":18.623126,"median":35.308236,"eighty":85.302091,"marketCap":46073289723.14},{"date":"2022-04-14","current":13.294114,"twenty":18.443795,"median":35.308236,"eighty":85.302091,"marketCap":46294767383.12},{"date":"2022-04-22","current":13.21633,"twenty":18.221438,"median":35.308236,"eighty":85.302091,"marketCap":45025239824.55},{"date":"2022-04-29","current":13.325935,"twenty":17.979017,"median":35.308236,"eighty":85.302091,"marketCap":45022632781.95},{"date":"2022-05-06","current":13.53454,"twenty":17.700642,"median":35.308236,"eighty":85.302091,"marketCap":45566277364},{"date":"2022-05-13","current":24.629857,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":43848144051.53},{"date":"2022-05-20","current":25.018997,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45016426783.75},{"date":"2022-05-27","current":25.119636,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45470626890.48},{"date":"2022-06-03","current":24.280973,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":42728413394.89},{"date":"2022-06-10","current":24.368194,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":41777808638.38},{"date":"2022-06-17","current":23.83145,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":40560767412.66},{"date":"2022-06-24","current":24.871564,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42352646298.73},{"date":"2022-07-01","current":25.220478,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42911856821.29},{"date":"2022-07-08","current":26.059148,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44046297256.04},{"date":"2022-07-15","current":26.763631,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44459950529.79},{"date":"2022-07-22","current":26.817305,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45321441244.41},{"date":"2022-07-29","current":30.743571,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45477961048.28},{"date":"2022-08-05","current":29.247514,"twenty":15.868566,"median":35.251678,"eighty":85.31532,"marketCap":42639852719.36},{"date":"2022-08-12","current":29.748811,"twenty":15.868566,"median":35.071486,"eighty":85.31532,"marketCap":43951767417.68},{"date":"2022-08-19","current":29.8898,"twenty":15.868566,"median":34.741035,"eighty":85.31532,"marketCap":43038704613},{"date":"2022-08-26","current":29.874135,"twenty":15.868566,"median":33.797644,"eighty":85.31532,"marketCap":42969756201.7},{"date":"2022-09-02","current":30.022957,"twenty":15.868566,"median":32.525364,"eighty":85.31532,"marketCap":42304023842.38},{"date":"2022-09-09","current":30.65741,"twenty":15.868566,"median":32.307982,"eighty":85.31532,"marketCap":42457872052.31},{"date":"2022-09-16","current":30.406762,"twenty":15.868566,"median":32.13589,"eighty":85.31532,"marketCap":41975860478.2},{"date":"2022-09-23","current":29.784868,"twenty":15.868566,"median":32.082779,"eighty":85.31532,"marketCap":41053322910.74},{"date":"2022-09-30","current":29.611929,"twenty":15.868566,"median":31.991351,"eighty":85.31532,"marketCap":40398024705.55},{"date":"2022-10-07","current":29.784868,"twenty":15.868566,"median":31.910861,"eighty":85.31532,"marketCap":40490115913.28},{"date":"2022-10-14","current":30.091442,"twenty":15.868566,"median":31.822929,"eighty":85.31532,"marketCap":40007811364.69},{"date":"2022-10-21","current":29.234607,"twenty":15.868566,"median":31.680102,"eighty":85.31532,"marketCap":38943108088.84},{"date":"2022-10-28","current":27.96678,"twenty":15.868566,"median":31.562866,"eighty":85.31532,"marketCap":40412932074.34},{"date":"2022-11-04","current":27.990228,"twenty":15.868566,"median":31.51076,"eighty":85.31532,"marketCap":40544936411.09},{"date":"2022-11-11","current":28.209015,"twenty":15.868566,"median":31.374814,"eighty":85.31532,"marketCap":43206259311.05},{"date":"2022-11-18","current":28.704934,"twenty":15.868566,"median":31.254645,"eighty":85.31532,"marketCap":43730486647.27},{"date":"2022-11-25","current":29.426933,"twenty":15.868566,"median":31.201154,"eighty":85.31532,"marketCap":45057111010.77},{"date":"2022-12-02","current":28.931014,"twenty":15.868566,"median":31.037761,"eighty":85.31532,"marketCap":45570767384.44},{"date":"2022-12-09","current":29.835336,"twenty":15.868566,"median":30.937343,"eighty":85.31532,"marketCap":46637499358.3},{"date":"2022-12-16","current":30.331255,"twenty":15.868566,"median":30.871973,"eighty":85.31532,"marketCap":47313819017.43},{"date":"2022-12-23","current":29.900973,"twenty":15.868566,"median":30.772934,"eighty":85.31532,"marketCap":47996239753.01},{"date":"2022-12-30","current":29.981195,"twenty":15.868566,"median":30.71556,"eighty":85.31532,"marketCap":48463304453.77},{"date":"2023-01-06","current":29.755114,"twenty":15.868566,"median":30.572454,"eighty":85.31532,"marketCap":47870974965.36},{"date":"2023-01-13","current":29.864508,"twenty":15.868566,"median":30.484406,"eighty":85.31532,"marketCap":49882681588.13},{"date":"2023-01-20","current":30.426063,"twenty":15.868566,"median":30.426063,"eighty":85.31532,"marketCap":49943652563.58},{"date":"2023-01-27","current":30.148932,"twenty":15.868566,"median":30.406762,"eighty":85.31532,"marketCap":49467797966.47},{"date":"2023-02-03","current":23.618692,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49524315647.28},{"date":"2023-02-10","current":23.884908,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49885153889.85},{"date":"2023-02-17","current":23.681054,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48373362782.36},{"date":"2023-02-24","current":23.799969,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":47942402215.74},{"date":"2023-03-03","current":24.043461,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48450666632.88},{"date":"2023-03-10","current":24.621048,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50074775527.78},{"date":"2023-03-17","current":24.802252,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51520828536.51},{"date":"2023-03-24","current":24.139732,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50698940566.02},{"date":"2023-03-31","current":24.63238,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":50868882296.85},{"date":"2023-04-06","current":24.898523,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":51908951328.51},{"date":"2023-04-14","current":25.289243,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52430478946.56},{"date":"2023-04-21","current":25.436471,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52090554629.18},{"date":"2023-04-28","current":25.549723,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52360758781.69},{"date":"2023-05-05","current":25.934781,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":53114594501.1},{"date":"2023-05-12","current":21.816188,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51463307525.88},{"date":"2023-05-19","current":21.919152,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50148262100.11},{"date":"2023-05-26","current":22.174322,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50264110513.18},{"date":"2023-06-02","current":21.909524,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50016322403.86},{"date":"2023-06-09","current":22.247876,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50740318667.02},{"date":"2023-06-16","current":22.419504,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50575421543.16},{"date":"2023-06-23","current":22.547244,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":50034367985.85},{"date":"2023-06-30","current":22.199081,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48652831553.96},{"date":"2023-07-07","current":21.625347,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47542321682.04},{"date":"2023-07-14","current":21.105555,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48436114801.39},{"date":"2023-07-21","current":21.512562,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48597606707.51},{"date":"2023-07-28","current":22.302484,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47655983749.28},{"date":"2023-08-04","current":22.405905,"twenty":15.864404,"median":30.349157,"eighty":85.328548,"marketCap":47472091400.73},{"date":"2023-08-11","current":22.962958,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47925971293.26},{"date":"2023-08-18","current":22.653484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":46744998549.67},{"date":"2023-08-25","current":22.947484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47472892956.93},{"date":"2023-09-01","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":48142626644.03},{"date":"2023-09-08","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":47619131084.19},{"date":"2023-09-15","current":25.06738,"twenty":15.864404,"median":30.239629,"eighty":85.328548,"marketCap":51339735089.9},{"date":"2023-09-22","current":24.298853,"twenty":15.864404,"median":30.152523,"eighty":85.328548,"marketCap":49671905160.78},{"date":"2023-09-29","current":23.9378,"twenty":15.864404,"median":30.101284,"eighty":85.328548,"marketCap":48306094881.06},{"date":"2023-10-06","current":23.12801,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":46912236069.61},{"date":"2023-10-13","current":23.4478,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":47185225879.19},{"date":"2023-10-20","current":22.447168,"twenty":15.864404,"median":30.035164,"eighty":85.328548,"marketCap":45133632614.81},{"date":"2023-10-27","current":33.018744,"twenty":15.848805,"median":30.061417,"eighty":85.468491,"marketCap":42045438777.36},{"date":"2023-11-03","current":33.977052,"twenty":15.848805,"median":30.109117,"eighty":85.468491,"marketCap":43262280273.82},{"date":"2023-11-10","current":34.001614,"twenty":15.848805,"median":30.156114,"eighty":85.468491,"marketCap":43146195810.29},{"date":"2023-11-17","current":34.509223,"twenty":15.848805,"median":30.265619,"eighty":85.468491,"marketCap":43924997173.45},{"date":"2023-11-24","current":34.411351,"twenty":15.848805,"median":30.338548,"eighty":85.468491,"marketCap":44071202551.42},{"date":"2023-12-01","current":34.149357,"twenty":15.848805,"median":30.406762,"eighty":85.468491,"marketCap":44271809028.5},{"date":"2023-12-08","current":33.224188,"twenty":15.856081,"median":30.46982,"eighty":85.355005,"marketCap":44164475676.92},{"date":"2023-12-15","current":32.708387,"twenty":15.856081,"median":30.676992,"eighty":85.355005,"marketCap":44261463171.18},{"date":"2023-12-22","current":32.732997,"twenty":15.856081,"median":31.207345,"eighty":85.355005,"marketCap":44132705649.12},{"date":"2023-12-29","current":33.191488,"twenty":15.848805,"median":31.270394,"eighty":85.468491,"marketCap":45078827041.22},{"date":"2024-01-05","current":35.107326,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46553386498.52},{"date":"2024-01-12","current":35.467569,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46529118760.4},{"date":"2024-01-19","current":35.574004,"twenty":15.834252,"median":31.485125,"eighty":85.695464,"marketCap":46054562134.98},{"date":"2024-01-26","current":35.287452,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45813893702.51},{"date":"2024-02-02","current":37.669312,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45919514328.61},{"date":"2024-02-09","current":37.493246,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":44733412617.38},{"date":"2024-02-16","current":38.84015,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46075141205.13},{"date":"2024-02-23","current":39.033823,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46211688108.13},{"date":"2024-03-01","current":38.637675,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45954550562.52},{"date":"2024-03-08","current":38.311953,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":46140815426.08},{"date":"2024-03-15","current":37.871788,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45561442683.96},{"date":"2024-03-22","current":38.796134,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45585981704.56},{"date":"2024-03-28","current":37.000261,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":43584427473.65},{"date":"2024-04-05","current":36.269795,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42616375994.67},{"date":"2024-04-12","current":36.498683,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42430179712.64},{"date":"2024-04-19","current":35.820825,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41294416133.79},{"date":"2024-04-26","current":35.997119,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41249770241.05},{"date":"2024-05-03","current":36.314041,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42076379836.26},{"date":"2024-05-10","current":36.349255,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41627594417.07},{"date":"2024-05-17","current":44.976968,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41733682877.63},{"date":"2024-05-24","current":45.020529,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41285104836.56},{"date":"2024-05-31","current":45.445251,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41644103120.04},{"date":"2024-06-07","current":46.087779,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42404430023},{"date":"2024-06-14","current":45.107651,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41300590483.72},{"date":"2024-06-21","current":43.866156,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":39610552206.76},{"date":"2024-06-28","current":45.436656,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":40691773038.88},{"date":"2024-07-05","current":46.209907,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41429859502.63},{"date":"2024-07-12","current":47.281654,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43144411716.7},{"date":"2024-07-19","current":46.533596,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42599959119.02},{"date":"2024-07-26","current":46.698609,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43774096625.98},{"date":"2024-08-02","current":44.272889,"twenty":15.841528,"median":31.485125,"eighty":84.95809,"marketCap":45300242074.37},{"date":"2024-08-09","current":43.014896,"twenty":15.841528,"median":31.485125,"eighty":84.034079,"marketCap":44025677518.59},{"date":"2024-08-16","current":45.710595,"twenty":15.841528,"median":31.485125,"eighty":83.611233,"marketCap":46246726032.37},{"date":"2024-08-23","current":46.418876,"twenty":15.841528,"median":31.485125,"eighty":83.285679,"marketCap":48080793858.92},{"date":"2024-08-30","current":45.805737,"twenty":15.841528,"median":31.485125,"eighty":82.840382,"marketCap":47110126928.06},{"date":"2024-09-06","current":45.150312,"twenty":15.841528,"median":31.485125,"eighty":82.567216,"marketCap":47633333133.33},{"date":"2024-09-13","current":43.733749,"twenty":15.841528,"median":31.485125,"eighty":82.35018,"marketCap":46692187320.02},{"date":"2024-09-20","current":45.192598,"twenty":15.841528,"median":31.485125,"eighty":81.917164,"marketCap":46914983400.73},{"date":"2024-09-27","current":44.008604,"twenty":15.841528,"median":31.485125,"eighty":81.717782,"marketCap":46173769906.47},{"date":"2024-10-04","current":44.8226,"twenty":15.841528,"median":31.485125,"eighty":81.193902,"marketCap":45207064894.75},{"date":"2024-10-11","current":45.034027,"twenty":15.841528,"median":31.485125,"eighty":80.903118,"marketCap":45273197191.14},{"date":"2024-10-18","current":45.203169,"twenty":15.841528,"median":31.485125,"eighty":80.121066,"marketCap":45314702691.87},{"date":"2024-10-25","current":43.395465,"twenty":15.841528,"median":31.485125,"eighty":79.259288,"marketCap":42802477236.79},{"date":"2024-11-01","current":23.34074,"twenty":15.841528,"median":31.394177,"eighty":76.252009,"marketCap":44255337707.7},{"date":"2024-11-08","current":23.061963,"twenty":15.841528,"median":31.223737,"eighty":52.659045,"marketCap":43818726338.15},{"date":"2024-11-15","current":23.302476,"twenty":15.841528,"median":30.720073,"eighty":52.113395,"marketCap":43649113935.95},{"date":"2024-11-22","current":22.482544,"twenty":15.841528,"median":30.492581,"eighty":51.914978,"marketCap":42094765685.01},{"date":"2024-11-29","current":22.318557,"twenty":15.841528,"median":30.428162,"eighty":51.719171,"marketCap":43004121919.03},{"date":"2024-12-06","current":22.537206,"twenty":15.841528,"median":30.363743,"eighty":51.54686,"marketCap":43593417925.5},{"date":"2024-12-13","current":22.602801,"twenty":15.841528,"median":30.265696,"eighty":51.06387,"marketCap":42654808427.14},{"date":"2024-12-20","current":22.438814,"twenty":15.841528,"median":30.156169,"eighty":50.729692,"marketCap":41620825476.96},{"date":"2024-12-27","current":22.89251,"twenty":15.841528,"median":30.11976,"eighty":50.270198,"marketCap":42157933916.75},{"date":"2025-01-03","current":22.854246,"twenty":15.841528,"median":30.084614,"eighty":49.695831,"marketCap":42120101324.52},{"date":"2025-01-10","current":22.526274,"twenty":15.834252,"median":30.039538,"eighty":48.706353,"marketCap":41387819255.78},{"date":"2025-01-17","current":22.072578,"twenty":15.834252,"median":29.98139,"eighty":47.742982,"marketCap":40954868347.09},{"date":"2025-01-24","current":22.056179,"twenty":15.834252,"median":29.928964,"eighty":47.376261,"marketCap":41086375616.12},{"date":"2025-01-31","current":32.066996,"twenty":15.834252,"median":29.8898,"eighty":47.184847,"marketCap":43068627249.87},{"date":"2025-02-07","current":31.518451,"twenty":15.834252,"median":29.8898,"eighty":46.698609,"marketCap":43370831342.3},{"date":"2025-02-14","current":31.625402,"twenty":15.834252,"median":29.8898,"eighty":46.623803,"marketCap":43271885610.15},{"date":"2025-02-21","current":32.135858,"twenty":15.834252,"median":29.8898,"eighty":46.463276,"marketCap":44737299221.36},{"date":"2025-02-28","current":33.019632,"twenty":15.834252,"median":29.8898,"eighty":46.1861,"marketCap":45710719655.87},{"date":"2025-03-07","current":33.965435,"twenty":15.826975,"median":29.881968,"eighty":45.994515,"marketCap":47968574450.17},{"date":"2025-03-14","current":32.579894,"twenty":15.826975,"median":29.881968,"eighty":45.856479,"marketCap":45709305301.84},{"date":"2025-03-21","current":33.462021,"twenty":15.826975,"median":29.881968,"eighty":45.756962,"marketCap":46697220950.86},{"date":"2025-03-28","current":32.837181,"twenty":15.826975,"median":29.881968,"eighty":45.646342,"marketCap":45537525126.69},{"date":"2025-04-04","current":32.910692,"twenty":15.826975,"median":29.881968,"eighty":45.486482,"marketCap":46959977925.4},{"date":"2025-04-11","current":28.911716,"twenty":15.834252,"median":29.864508,"eighty":45.423604,"marketCap":41903036554.51},{"date":"2025-04-17","current":30.516053,"twenty":15.834252,"median":29.864508,"eighty":45.37687,"marketCap":44665727413.14},{"date":"2025-04-25","current":31.299454,"twenty":15.826975,"median":29.853656,"eighty":45.205165,"marketCap":45236702475.67},{"date":"2025-05-02","current":32.353752,"twenty":15.826975,"median":29.853656,"eighty":45.143969,"marketCap":46627023849.03},{"date":"2025-05-09","current":62.186826,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46246122430},{"date":"2025-05-16","current":59.013194,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":43629573670.78},{"date":"2025-05-23","current":60.272181,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":45243750600.82},{"date":"2025-05-30","current":62.428377,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46713186360.41},{"date":"2025-06-06","current":62.153426,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46690667816.43},{"date":"2025-06-13","current":62.934861,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":47259274399.65},{"date":"2025-06-20","current":62.052124,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45950911927.98},{"date":"2025-06-27","current":63.18087,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47191840400.65},{"date":"2025-07-03","current":64.005724,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47693415916.83},{"date":"2025-07-11","current":64.055104,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47209686047.66},{"date":"2025-07-18","current":63.513752,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46158538139.51},{"date":"2025-07-25","current":63.308916,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46555456308.17},{"date":"2025-08-01","current":48.106805,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43759985637.51},{"date":"2025-08-08","current":48.654381,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45191185373.67},{"date":"2025-08-15","current":50.297108,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46622420863.67},{"date":"2025-08-22","current":52.350517,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":48379407617.45},{"date":"2025-08-29","current":50.434002,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46969989485.26},{"date":"2025-09-05","current":52.179399,"twenty":15.818034,"median":29.83907,"eighty":45.065741,"marketCap":48057469940.35},{"date":"2025-09-12","current":51.255365,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47683369897.6},{"date":"2025-09-19","current":51.084248,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47282912126.15},{"date":"2025-09-26","current":50.627935,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46290416349.68},{"date":"2025-10-03","current":48.574526,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45123442627.46},{"date":"2025-10-10","current":48.163844,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43057554125.18},{"date":"2025-10-17","current":47.810202,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43420086875.26},{"date":"2025-10-24","current":49.008023,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43939898848.11},{"date":"2025-10-31","current":196.128812,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":42096877735.37},{"date":"2025-11-07","current":199.628241,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":43122516182.74},{"date":"2025-11-14","current":212.188582,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45471927947.27},{"date":"2025-11-21","current":211.902035,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":44500274886.11},{"date":"2025-11-28","current":215.197333,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45545101317.81},{"date":"2025-12-05","current":210.61257,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45011991214.34},{"date":"2025-12-12","current":212.427372,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45254225772.44},{"date":"2025-12-19","current":219.877613,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":46788038894.3},{"date":"2025-12-26","current":232.581228,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":49307900125.5},{"date":"2026-01-02","current":230.9097,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":48729268900.59},{"date":"2026-01-09","current":242.610705,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51132650268.4},{"date":"2026-01-16","current":242.276399,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":50569808771.94},{"date":"2026-01-23","current":244.329994,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51041613744.96},{"date":"2026-01-30","current":73.324517,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":54139767928.12},{"date":"2026-02-06","current":77.171186,"twenty":15.819699,"median":29.842804,"eighty":45.118598,"marketCap":55518181293.68},{"date":"2026-02-13","current":78.528012,"twenty":15.819699,"median":29.842804,"eighty":45.203169,"marketCap":58174278066.56},{"date":"2026-02-20","current":80.98988,"twenty":15.819699,"median":29.842804,"eighty":45.358128,"marketCap":59032990935.72},{"date":"2026-02-27","current":81.400335,"twenty":15.819699,"median":29.842804,"eighty":45.393454,"marketCap":58849002644.08},{"date":"2026-03-06","current":79.553824,"twenty":15.819699,"median":29.842804,"eighty":45.478025,"marketCap":56940998250.88},{"date":"2026-03-13","current":79.357982,"twenty":15.819699,"median":29.842804,"eighty":45.710595,"marketCap":56281429903.04},{"date":"2026-03-20","current":80.68691,"twenty":15.819699,"median":29.842804,"eighty":45.805737,"marketCap":57640580474.28},{"date":"2026-03-27","current":81.700474,"twenty":15.819699,"median":29.842804,"eighty":45.946205,"marketCap":57787054549.19},{"date":"2026-04-02","current":82.399965,"twenty":15.819699,"median":29.842804,"eighty":46.155453,"marketCap":58414619614.42},{"date":"2026-04-10","current":80.189575,"twenty":15.819699,"median":29.842804,"eighty":46.418876,"marketCap":56894786236.46},{"date":"2026-04-17","current":78.147063,"twenty":15.819699,"median":29.842804,"eighty":46.632604,"marketCap":55443526794.1},{"date":"2026-04-24","current":74.636784,"twenty":15.819699,"median":29.842804,"eighty":46.753613,"marketCap":52882297496.5},{"date":"2026-05-01","current":73.293741,"twenty":15.819699,"median":29.842804,"eighty":47.281654,"marketCap":52807070808.15},{"date":"2026-05-08","current":72.930001,"twenty":15.819699,"median":29.842804,"eighty":47.890056,"marketCap":52641729349.45}],"updateTime":1778530928502},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TAK\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621482702","title":"Market Chatter: Takeda, Eli Lilly to Face Class Action Over Actos Cancer Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2621482702","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621482702?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:58","pubTimestamp":1774277895,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  and Eli Lilly  will face a multibillion-dollar class action accusing them of concealing diabetes drug Actos' bladder cancer risk after the US Supreme Court rejected their appeal, Bloomberg reported Monday, citing a court order.The high court rejected the companies' argument that the lawsuit should not go forward as a class action on behalf of tens of thousands of insurers and third-party payers of Actos prescriptions because the plaintiffs provided no viable way of excluding those who did not suffer any harm, according to the report.Takeda Pharmaceutical and Eli Lilly did not immediately respond to requests for comment from MT Newswires.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2746668461.USD","LU1064131342.USD","LU2112291526.USD","LU0006306889.USD","LU2023250330.USD","LU2361045086.USD","IE00BJJMRX11.SGD","LU2357305700.SGD","LU2491050071.SGD","LU1093756168.USD","BK4585","LU0708995401.HKD","SG9999014914.USD","LU2106854487.HKD","SG9999018865.SGD","IE00BWXC8680.SGD","LU1232071149.USD","IE0009355771.USD","LU2237438978.USD","LU0097036916.USD","LU1720051108.HKD","LU2089283258.USD","IE00BK4W5L77.USD","LU2237443895.HKD","SG9999015945.SGD","SGXZ81514606.USD","LU2211815571.USD","LU0158827948.USD","IE00BN29S564.USD","LU2746668974.SGD","LU2087625088.SGD","LU0316494557.USD","LU2552382215.SGD","LLII","BK4007","IE00BJJMRY28.SGD","LU1868836757.USD","LU0320765992.SGD","LU1917777945.USD","SGXZ31699556.SGD","LU2417539215.USD","LU2360106947.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","SG9999013999.USD","BK4534","LU0158827781.USD","LU2271345857.HKD","LU1057294990.SGD","SG9999014898.SGD","LU0466842654.USD","GB00BDT5M118.USD","BK4581","LU2750360641.GBP","LU2756315318.SGD","LU0225283273.USD","LU0354030438.USD","LU0683600562.USD","LU1623119135.USD","LU2237443622.USD","LU0820561909.HKD","LU2602419157.SGD","LU1035775433.USD","LU1868836914.USD","TAK","LU2237443978.SGD","LU2108987350.USD","SG9999015986.USD","BK4516","LU2168564222.USD","LU2552382058.USD","LU0471298777.SGD","LU0417517546.SGD","LU2361044865.SGD","LU1720051017.SGD","IE00BFSS7M15.SGD","IE00BFSS8Q28.SGD","LU2756315664.SGD","IE0004445239.USD","LU1868836591.USD","LU2237443382.USD","IE00BJJMRZ35.SGD","IE00BK4W5M84.HKD","LU1989771016.USD","IE00BKDWB100.SGD","LU2063271972.USD","LU0109391861.USD","LU2491050154.USD","IE0005OL40V9.USD","LU1093756325.SGD","IE00B1BXHZ80.USD","LU0061475181.USD","LU2023251221.USD","ELIS","LU2089284900.SGD","SG9999015978.USD","LU0114720955.EUR","LU0385154629.USD","LU1069344957.HKD","LU2471134879.HKD","LU0882574055.USD","LU1548497426.USD","LU0964807845.USD","LU0353189763.USD","LU0823416689.USD","LU1551013342.USD","IE00B4JS1V06.HKD","LU1868837300.USD","LU1804176565.USD","IE0001KFT4U8.USD","BK4588","SG9999014906.USD","SG9999001176.SGD","LU2168564495.EUR","LU1974910355.USD","LU1629891620.HKD","LU0256863902.USD","SGXZ57979304.SGD","LU0266013472.USD","SG9999018857.SGD","IE00BKPKM429.USD","LU0109394709.USD","LU0238689110.USD","LU2168564065.EUR","LU0096364046.USD","IE00B2B36J28.USD","LLYX","LU0354030511.USD","LU2491049909.HKD","LU0234572021.USD","LU0820561818.USD","LU2236285917.USD","ELIL","SGXZ51526630.SGD","IE00BFTCPJ56.SGD","LU0882574139.USD","LU0787776722.HKD","LU2028103732.USD","LU2265009873.SGD","SG9999001176.USD","LU2237443465.HKD","LU1712237335.SGD","LU2089984988.USD","LU1023059063.AUD","LU1551013425.SGD","SG9999015952.SGD","LLYZ","LU2461242641.AUD","LU0106261372.USD","LU2213496289.HKD","LU2750360997.AUD","LU0640476718.USD","SG9999014880.SGD","SG9999017495.SGD","LU2471134952.CNY","LU0672654240.SGD","LU0058720904.USD","LU2324357040.USD","LU0471298694.HKD","LU2111349929.HKD","LU0823434740.USD","LU0198837287.USD","LU0456855351.SGD","IE00B1XK9C88.USD","LLY","LU0289739699.SGD","LU1061106388.HKD","LU0432979614.USD","LU1291159041.SGD","LU2023250504.SGD","LU2264538146.SGD","LU2361044949.HKD","LU0256863811.USD","LU1127390331.HKD","LU1323610961.USD","LU1366192091.USD","LU2896262040.SGD","LU1145028129.USD","LU1988902786.USD","LU2168564149.EUR","LU1280957306.USD","LU1814569148.SGD","LU0786609619.USD","LU0079474960.USD","LU1983299246.USD","LU2462157665.USD","IE0002141913.USD","IE00B7KXQ091.USD","LU2456880835.USD","LU0689472784.USD","IE0004445015.USD","IE00B775H168.HKD","LU1868837136.USD","LU1267930730.SGD","LU0823434583.USD","BK4599","LU0353189680.USD","LU0323591593.USD","BK4533","LU2471134523.USD","LU0320765059.SGD","LU2237443549.SGD","LU0820562030.AUD","LU2552382132.HKD","LU0943347566.SGD","LU0122379950.USD","IE00BJLML261.HKD","IE00BJT1NW94.SGD","LU0203201768.USD","LU0203202063.USD","LU2168563687.JPY","LU0889565916.HKD","LU0210536198.USD","LU2471134796.USD","SGXZ99366536.SGD","LU0094547139.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2619111631","title":"Takeda’s EXPLORHAE HAE Study in Egypt: Real‑World Data With Long‑Term Investor Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2619111631","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619111631?lang=en_us&edition=fundamental","pubTime":"2026-03-14 00:31","pubTimestamp":1773419507,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is launching a real‑world study in Egypt on ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-explorhae-hae-study-in-egypt-real‑world-data-with-long‑term-investor-upside?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-explorhae-hae-study-in-egypt-real‑world-data-with-long‑term-investor-upside?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0106261612.USD","BK4007","HAE","LU1169589451.USD","LU0205193047.USD","LU1169590202.USD","BK4198","IE00B64QTZ34.USD","TAK","LU0012050646.USD","LU0205194284.USD","IE00B19Z6F94.USD","IE0034390439.USD","IE00BLDYK493.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617650744","title":"These 8 drugs could help fight dementia - and they're already on the market","url":"https://stock-news.laohu8.com/highlight/detail?id=2617650744","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617650744?lang=en_us&edition=fundamental","pubTime":"2026-03-07 23:00","pubTimestamp":1772895600,"startTime":"0","endTime":"0","summary":"Getting yourself vaccinated against shingles doesn't just protect you against that painful and debilitating disease - it may also slash your risk of developing Alzheimer's by as much as 20%, according to a recent study involving hundreds of thousands of people.And that finding, based on the closest thing you can get to gold-standard methodology in the real world, is among the reasons that a worldwide group of scientists have placed the shingles vaccine at the head of a list of drugs already on the market that they want studied in more detail for their possible benefits in the war on dementia.Among them is the erectile-dysfunction pill Viagra . It was first tested in the 1980s as a treatment for angina, the heart disease, and it is currently used for treatment of pulmonary hypertension as well as ED. Researchers cited various medical mechanisms by which the drug could help prevent Alzheimer's or other dementias. Two large studies based on health-insurance databases found that those who ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965508806.USD","LU0985481810.HKD","LU2360032135.SGD","LU1069347547.HKD","LU1066051225.USD","SG9999014567.USD","LU0006306889.USD","LU0130102774.USD","LU1585245621.USD","IE0002141913.USD","MRK","SG9999014575.USD","BK4516","BK4568","LU1093756168.USD","LU0225771236.USD","LU1037948541.HKD","LU0320765646.SGD","LU0985320562.USD","LU1983299246.USD","IE00B4R5TH58.HKD","IE0009355771.USD","SG9999003800.SGD","LU0965509101.SGD","LU2125154778.USD","LU0266013472.USD","LU1162221912.USD","LU0456855351.SGD","LU1037948897.HKD","LU0980610538.SGD","LU1699723380.USD","LU1894683264.USD","LU2361044865.SGD","LU0225284248.USD","IE0002270589.USD","LU0170899867.USD","LU0106261372.USD","LU0868494617.USD","LU2461242641.AUD","BK4559","LU0965509010.AUD","SG9999001440.SGD","LU1057294990.SGD","SG9999015358.SGD","IE00B2B36J28.USD","LU0306807586.USD","LU0203347892.USD","BK4534","LU0208291251.USD","LU1829250122.USD","LU2106854487.HKD","BK4592","LU1934455194.USD","LU1917777945.USD","LU1883839398.USD","LU1023059063.AUD","LU1093756325.SGD","LU0861579265.USD","LU2361044949.HKD","SG9999014559.SGD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","SG9999001176.SGD","SG9999011175.SGD","LU0070302665.USD","LU1116320901.HKD","LU2023250504.SGD","SG9999015341.SGD","SGXZ57979304.SGD","BK4533","LU0058720904.USD","SG9999002224.SGD","LU1989772840.SGD","LU0648001328.SGD","BK4550","LU1116320737.USD","GSK.UK","LU0130517989.USD","GSKH","LU1430594728.SGD","SG9999001176.USD","LU1941712348.USD","LU0321505868.SGD","LU0942090050.USD","LU2361045086.USD","LU0265550946.USD","LU2112291526.USD","NVS","TAK","LU1066051498.USD","LU0238689110.USD","LU2023250843.SGD","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU1934455863.HKD","LU1894683348.USD","LU0234572021.USD","LU0265550359.USD","IE00BLSP4452.SGD","LU1201861249.SGD","LU1035773651.USD","LU0203345920.USD","BK4588","SG9999002232.USD","LU0098860793.USD","LU2125154935.USD","GSK","IE00BJT1NW94.SGD","LU1066051811.HKD","LU0306806265.USD","BK4585","LU1989771016.USD","LU2324357040.USD","BK4599","LU0477156953.USD","LU1974910355.USD","LU0432979614.USD","IE00BLSP4239.USD","LU0289739699.SGD","BK4581","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU0320765489.SGD","IE00BN8TJ469.HKD","IE00BSNM7G36.USD","LU1989772923.USD","LU0868494708.USD","BK4578","LU1061106388.HKD","LU1934455277.USD","LU0122379950.USD","SG9999014542.SGD","IE00B1BXHZ80.USD","SG9999013999.USD","PFE","BK4532","LU2089984988.USD","LU1291159041.SGD","LU0965509283.SGD","LU0211331839.USD","LU2468319806.SGD","LU1941712264.USD","LU0321505439.SGD","LU1571399168.USD","IE00B19Z3581.USD","BK4007","LU1929549753.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617524526","title":"Takeda’s TAK-861 Narcolepsy Study Moves Forward, Extending the Long-Term Bet on Sleep Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2617524526","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617524526?lang=en_us&edition=fundamental","pubTime":"2026-03-06 00:32","pubTimestamp":1772728348,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. The new Takeda study, officially titled “A Long-term Exte...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-tak-861-narcolepsy-study-moves-forward-extending-the-long-term-bet-on-sleep-disorders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-tak-861-narcolepsy-study-moves-forward-extending-the-long-term-bet-on-sleep-disorders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617245975","title":"Takeda Advances Fazirsiran Phase 3 Liver Study, Keeping Rare-Disease Growth Story in Play","url":"https://stock-news.laohu8.com/highlight/detail?id=2617245975","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617245975?lang=en_us&edition=fundamental","pubTime":"2026-03-06 00:32","pubTimestamp":1772728333,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running a late-stage study called “A Rand...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-fazirsiran-phase-3-liver-study-keeping-rare-disease-growth-story-in-play?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-fazirsiran-phase-3-liver-study-keeping-rare-disease-growth-story-in-play?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617566597","title":"Sector Update: Health Care Stocks Advance Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2617566597","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617566597?lang=en_us&edition=fundamental","pubTime":"2026-03-05 04:52","pubTimestamp":1772657524,"startTime":"0","endTime":"0","summary":"Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index gaining 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.3%.The iShares Biotechnology ETF (I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4551","BK4581","BK4548","MRNA","BK4007","BK4139","MRNX","IBB","BK4568","BK4533","BK4501","BK4585","BK4532","MRNY","TAK","VCEL","XLV","BK4539","ABUS","BK4534","BK4121","BK4588","XBI","STVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617565993","title":"Market Chatter: Takeda Pharmaceutical to Cut 400 US Jobs, Invest in Blood Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2617565993","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617565993?lang=en_us&edition=fundamental","pubTime":"2026-03-05 04:03","pubTimestamp":1772654588,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical (TAK) is cutting 400 US jobs while investing in blood products and other priority areas, as the company intends to improve its profitability in the US market, Nikkei Asia reporte","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616332612","title":"Press Release: Alan Walshe Appointed General Manager of Takeda Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332612","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616332612?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:59","pubTimestamp":1772456340,"startTime":"0","endTime":"0","summary":"A proven people--focused commercial strategist with extensive global experience to lead Takeda Canada's next chapter of growth and impact.TORONTO, March 2, 2026  /CNW/ - Takeda Canada Inc.  is pleased to announce the appointment of Alan Walshe as General Manager for Canada.Takeda Canada Inc. is the Canadian organization of Takeda Pharmaceutical Company Limited .  Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the plan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616433356","title":"Takeda, Protagonist announce FDA acceptance of rusfertide new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2616433356","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616433356?lang=en_us&edition=fundamental","pubTime":"2026-03-02 18:30","pubTimestamp":1772447427,"startTime":"0","endTime":"0","summary":"Takeda (TAK) and Protagonist Therapeutics (PTGX) announced that the FDA accepted the new drug application and granted priority review for rusfertid...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-protagonist-announce-fda-acceptance-of-rusfertide-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-protagonist-announce-fda-acceptance-of-rusfertide-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX","TAK","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613295708","title":"Takeda’s Cuvitru Safety Study: What a New Japanese Registry Update Means for TAK Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2613295708","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613295708?lang=en_us&edition=fundamental","pubTime":"2026-02-21 00:33","pubTimestamp":1771605234,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda’s new post-marketing database survey tracks the re...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-cuvitru-safety-study-what-a-new-japanese-registry-update-means-for-tak-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-cuvitru-safety-study-what-a-new-japanese-registry-update-means-for-tak-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","ISBC","BK4211","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612938922","title":"Takeda Shares Down After Entyvio Shows Strong Results In Ulcerative Colitis Trial In Children, Shows Potential To Address Treatment Gaps","url":"https://stock-news.laohu8.com/highlight/detail?id=2612938922","media":"Benzinga_recent_news","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612938922?lang=en_us&edition=fundamental","pubTime":"2026-02-20 23:17","pubTimestamp":1771600620,"startTime":"0","endTime":"0","summary":"Takeda shares are down slightly on Friday morning after positive Phase 3 Entyvio data show strong remission rates in ulcerative colitis trial.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/20/Takeda-Pharmaceutical-Company.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/20/Takeda-Pharmaceutical-Company.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/large-cap/26/02/50751295/takeda-shares-down-after-entyvio-shows-strong-results-in-ulcerative-colitis-trial-in-children-shows-potential-to-address-treatment-gaps","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/large-cap/26/02/50751295/takeda-shares-down-after-entyvio-shows-strong-results-in-ulcerative-colitis-trial-in-children-shows-potential-to-address-treatment-gaps","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","TAK","SMA","BK4217"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612488284","title":"Takeda Reports 47% of Patients Met Primary Endpoint in Entyvio Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2612488284","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612488284?lang=en_us&edition=fundamental","pubTime":"2026-02-20 01:43","pubTimestamp":1771522980,"startTime":"0","endTime":"0","summary":"Takeda said data from a Phase 3 trial showed its Entyvio treatment provides the  possibility of achieving clinical remission in pediatric patients with a form of gastrointestinal tract disease.The pharmaceutical company said Thursday that about 47% of patients between the ages of two and 17 reached the primary endpoint of clinical remission after 54 weeks. About 35% reached clinical remission after 14 weeks, the secondary endpoint of the study.Entyvio, the brand name for vedolizumab, is designed to treat moderate to severe active ulcerative colitis, a disease involving chronic inflammation of the GI tract.\"We observed clinically meaningful improvements with vedolizumab in an especially difficult-to-treat patient population--children and adolescents who had failed on the current standard of care, including conventional therapies and/or tumor necrosis factor  antagonists,\" MNGI Digestive Health gastroenterologist Ramalingam Arumugam, one of the investigators on the study, said.Takeda sai","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Takeda Reports 47% of Patients Met Primary Endpoint in Entyvio Trial","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612284354","title":"Takeda announces data from Phase 3 KEPLER trial of ENTYVIO","url":"https://stock-news.laohu8.com/highlight/detail?id=2612284354","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612284354?lang=en_us&edition=fundamental","pubTime":"2026-02-20 01:11","pubTimestamp":1771521100,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced data from the pivotal Phase 3 KEPLER trial, which demonstrated that ENTYVIO can offer the possibility of clinical remission ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-announces-data-from-phase-3-kepler-trial-of-entyvio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-announces-data-from-phase-3-kepler-trial-of-entyvio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612159447","title":"Takeda’s New Stroke Trial Adds Long-Term Optionality to TAK’s Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2612159447","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612159447?lang=en_us&edition=fundamental","pubTime":"2026-02-19 00:31","pubTimestamp":1771432296,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is launching a Phase 2 trial titled “A Phase...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-new-stroke-trial-adds-long-term-optionality-to-taks-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-new-stroke-trial-adds-long-term-optionality-to-taks-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612471114","title":"Takeda’s HyQvia Study Tracks Real-World Use in Multiple Myeloma, Offering Gradual Upside for TAK Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2612471114","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612471114?lang=en_us&edition=fundamental","pubTime":"2026-02-19 00:31","pubTimestamp":1771432281,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is running a prospective, observational study call...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-hyqvia-study-tracks-real-world-use-in-multiple-myeloma-offering-gradual-upside-for-tak-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-hyqvia-study-tracks-real-world-use-in-multiple-myeloma-offering-gradual-upside-for-tak-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007","BK4211","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612471634","title":"Takeda Targets Better Hereditary Angioedema Diagnosis With New AHAE Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2612471634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612471634?lang=en_us&edition=fundamental","pubTime":"2026-02-19 00:31","pubTimestamp":1771432268,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is backing a new diagnostic study for heredi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-targets-better-hereditary-angioedema-diagnosis-with-new-ahae-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-targets-better-hereditary-angioedema-diagnosis-with-new-ahae-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612549442","title":"Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2612549442","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612549442?lang=en_us&edition=fundamental","pubTime":"2026-02-18 23:45","pubTimestamp":1771429534,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were higher Wednesday morning, up 0.6% to 2,985.58 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by e-commerce company PDD  and Takeda Pharmaceutical , which advanced 2.1% and 2%, respectively.They were followed by financial technology companies LexinFintech  and FinVolution , which climbed 1.8% and 1.6%, respectively.The decliners from North Asia were led by sports and social business company Leifras  and Internet and data center service provider VNET , which fell 12% and 9.6%, respectively.They were followed by game-related entertainment and services provider Huya , which shed 2.4%.From South Asia, the gainers were led by IT service management company Trident Digital Tech  and tech conglomerate Sea , which gained 4.7% and 3.1%, respectively.The decliners from South Asia were led by telecom Telkom Indonesia , which decreased 0.7%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1769817179.HKD","LU0589944569.HKD","LU0328353924.USD","LU1770034418.SGD","LU0823397285.USD","LU0541501648.USD","LU0516423174.USD","HUYA","BK4166","LU1719994722.HKD","LU1323998911.USD","SG9999006266.SGD","LU0143863784.USD","LU1242518931.SGD","SG9999013486.USD","HK0000306685.HKD","LU2152927971.USD","BK4509","LU0561508036.HKD","LU1235295612.USD","LU1961090484.USD","LU2039709279.SGD","LU0572939691.SGD","LU0370786039.SGD","LU1769817096.USD","BK4115","LU0329678337.USD","SGXZ58947870.SGD","LU1868837722.USD","LU0289960550.SGD","BK4535","LU2045819591.USD","BK4220","LU0348805143.USD","LU0516422952.EUR","SG9999005177.SGD","BK4501","BK4558","BK7093","LU2065169927.USD","BK4204","LU0541502299.USD","LU0143863198.USD","BK4503","BK4007","VNET","LU2065170008.USD","LU0264606111.USD","LU0823426308.USD","LU2257852520.SGD","LU0345775950.USD","LU0348825331.USD","HK0000306701.USD","LU0175139822.USD","LU0605514214.HKD","SE","LU0499858438.USD","BK4513","BK4107","LU0456846285.SGD","LU0532188223.SGD","BK4579","LU2360107671.USD","IE00B3M56506.USD","SG9999002463.SGD","LU0348827113.USD","LU0359201612.USD","LU0594300179.USD","HK0000320223.HKD","LU1988902786.USD","LU0594300419.USD","LU0683595622.HKD","SG9999002562.SGD","LU0164865239.USD","LU0259732245.USD","LU0588546209.SGD","LU0823038988.USD","LU1981816686.USD","BK4588","LU0072462343.USD","LU1808992512.USD","IE00B0JY6N72.USD","LU0359201885.HKD","LU0737861269.HKD","LU0210526637.USD","LU0633140560.USD","LU1046422090.SGD","BK4585","LU2211817866.USD","SG9999013478.USD","LU2543165471.USD","BK4551","LU0359202008.SGD","LU0516422366.SGD","LU2125910500.SGD","BK4548","LU0878005551.USD","BK4553","LU1251922891.USD","LU0235996351.USD","SG9999002414.USD","LU0821914370.USD","TAK","LU0251143029.SGD","BK4607","LU2065171311.SGD","LU2087589342.USD","BK4085","LU1242518857.USD","LU2264538146.SGD","LU0502904849.HKD","IE0001KFT4U8.USD","SG9999002620.SGD","LX","IE00B29SXG58.USD","LU0047713382.USD","LU0708995583.HKD","BK4526","LU0633140727.USD","LU0823413660.USD","SG9999013460.SGD","TDTH","LU0261945553.USD","LU2399975544.HKD","SG9999002406.SGD","LU0048573645.USD","LU0499858602.USD","LU0823397103.USD","LU0737861772.HKD","BK4505","BK4117","LU1770036033.HKD","LU0327786744.USD","BK4122","LU0315179316.USD","LU0823426480.USD","LU1171460220.USD","LU1794554557.SGD","LU0052750758.USD","LU0455707207.USD","LU1861217088.USD","LU1868838027.USD","TLK","LU0039217434.USD","LU0345776255.USD","IE00BD6J9T35.USD","LU1720050803.USD","LU2242644610.SGD","LU0140636845.USD","LU0871576103.HKD","PDD","LU0210637038.USD","IE00BGV7N243.SGD","BK4531","LU1048588211.SGD","SG9999014674.SGD","LU1303224171.USD","SG9999002679.SGD","LU2125910849.SGD","SG9999001135.SGD","LU1868837565.USD","IE0031814969.USD","LU1048596156.SGD","LU2177674079.SGD","LU1861220207.SGD","LU1839390173.USD","LFS","LU0307460666.USD","SG9999014492.USD","LU0231483743.USD","LU0117841782.USD","LU0572944931.SGD","BK4116","LU1956131251.USD","SG9999002828.SGD","IE0034224299.USD","LU0348788117.USD","HK0000320264.USD","LU0048580855.USD","BK4134","BK4566","FINV","LU0417516902.SGD","LU0650527681.SGD","LU1880383366.USD","LU0531971595.HKD","LU0823039010.USD","BK4581","LU0823413587.USD","LU1023057109.AUD","SG9999004360.SGD","LU0329678170.USD","LU0456827905.SGD","LU0051755006.USD","BK4554","LU2065171402.SGD","LU1064131342.USD","LU2238330802.EUR","SG9999002604.SGD","SG9999014484.SGD","LU1880383440.USD","LU0572940350.SGD","LU0979878070.USD","LU0320764599.SGD","LU0049112450.USD","LU0516423091.SGD","LU0441851309.USD","LU2008162690.USD","LU0516422440.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2611613521","title":"Takeda Advances Phase 3 Teen Depression Trial, Underscoring Its Neuroscience Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2611613521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611613521?lang=en_us&edition=fundamental","pubTime":"2026-02-14 00:31","pubTimestamp":1771000303,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running a Phase 3 study called “A Randomi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-phase-3-teen-depression-trial-underscoring-its-neuroscience-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-phase-3-teen-depression-trial-underscoring-its-neuroscience-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611341161","title":"Takeda Pushes Pediatric Psoriasis Drug TAK-279 Forward With New Phase 3 Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2611341161","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611341161?lang=en_us&edition=fundamental","pubTime":"2026-02-14 00:31","pubTimestamp":1771000277,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is running a phase 3 trial to test its drug zasoci...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-pushes-pediatric-psoriasis-drug-tak-279-forward-with-new-phase-3-trial-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-pushes-pediatric-psoriasis-drug-tak-279-forward-with-new-phase-3-trial-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610897952","title":"Takeda Advances Oral Crohn’s Disease Drug TAK-279 With Active Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2610897952","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610897952?lang=en_us&edition=fundamental","pubTime":"2026-02-12 00:31","pubTimestamp":1770827515,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running a mid-stage study called “A Phase...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-oral-crohns-disease-drug-tak-279-with-active-mid-stage-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-oral-crohns-disease-drug-tak-279-with-active-mid-stage-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007","SSI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":68,"code":"91000000","status":"200"}]}}